NeuroSense Therapeutics Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CLEAR STREET GROUP INC. | 11/14/2025 | 63.69 K | $24.20 K | 100.00% | 0.34% |
| UBS GROUP AG | 11/13/2025 | 1.28 K | $397 | -12.93% | 0.01% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
NeuroSense Therapeutics Ltd. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of NeuroSense Therapeutics Ltd.. The most heavily invested institutionals were:
Clear Street Group Inc.: 63,685
UBS Group AG: 1,280
CLEAR STREET LLC: 63,685
Empery Asset Management, LP: 160,000
0.35% of NeuroSense Therapeutics Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 288.65 K shares in the last 24 months. This purchase volume represents approximately $112.57 K in transactions.